75834-231-10 |
75834-231 |
HUMAN PRESCRIPTION DRUG |
Remifentanil hydrochloride |
Remifentanil hydrochloride |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20240904 |
N/A |
ANDA |
ANDA215635 |
Nivagen Pharmaceuticals, Inc. |
REMIFENTANIL HYDROCHLORIDE |
2 mg/1 |
10 VIAL, GLASS in 1 CARTON (75834-231-10) / 2 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (75834-231-01) |
75834-232-10 |
75834-232 |
HUMAN PRESCRIPTION DRUG |
Remifentanil hydrochloride |
Remifentanil hydrochloride |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20240904 |
N/A |
ANDA |
ANDA215635 |
Nivagen Pharmaceuticals, Inc. |
REMIFENTANIL HYDROCHLORIDE |
5 mg/1 |
10 VIAL, GLASS in 1 CARTON (75834-232-10) / 5 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (75834-232-01) |
75834-230-10 |
75834-230 |
HUMAN PRESCRIPTION DRUG |
Remifentanil hydrochloride |
Remifentanil hydrochloride |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
INTRAVENOUS |
20240904 |
N/A |
ANDA |
ANDA215635 |
Nivagen Pharmaceuticals, Inc. |
REMIFENTANIL HYDROCHLORIDE |
1 mg/1 |
10 VIAL, GLASS in 1 CARTON (75834-230-10) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (75834-230-01) |